Progesterone

Progesterone is the dominant hormone of the luteal phase. It is produced by the corpus luteum, the structure that forms from the ruptured follicle after ovulation. Progesterone has a distinctive set of effects: it raises basal body temperature, supports endometrial preparation for implantation, promotes sleep onset, and via its metabolite allopregnanolone, modulates GABA in the brain.

The cyclic rise and fall of progesterone, combined with estrogen, explains most of the experiential difference between cycle phases for users who notice phase patterns.

How progesterone cycles

Unlike estrogen, progesterone is essentially flat through the follicular phase. The corpus luteum does not exist yet, so there is no significant production. The pattern:

  • Days 1 to 13 (menstrual + follicular): very low.
  • Days 14 to 16 (ovulatory): starts rising as corpus luteum forms.
  • Days 17 to 22 (early luteal): peak production. Levels are 10 to 20x higher than follicular baseline.
  • Days 23 to 28 (late luteal): sharp drop as corpus luteum dies (unless pregnancy occurs). This drop is the trigger for menstruation.

The drop is what matters for PMS: the brain has spent two weeks adapting to high progesterone, and the sudden withdrawal in late luteal disrupts the systems it was modulating.

What progesterone does

Raises body temperature. Progesterone has a direct thermogenic effect via hypothalamic temperature regulation. Basal body temperature rises by roughly 0.5°F (0.3°C) within 24 to 48 hours of ovulation and stays elevated until menstruation. This shift is the retrospective marker of ovulation used by fertility awareness methods.

Supports endometrial preparation. Progesterone transforms the estrogen-primed endometrium into a secretory state that can support implantation if pregnancy occurs.

Promotes sleep onset. Progesterone has GABAergic effects (via allopregnanolone) that make it sleep-promoting. Many users sleep more deeply in early luteal phase.

Disrupts late-luteal sleep. The high progesterone of mid-luteal is sleep-promoting; the sharp drop in late luteal disrupts sleep architecture. Both ends of the luteal phase have sleep effects, in opposite directions.

Modulates mood via GABA. Allopregnanolone (a progesterone metabolite) binds to GABA receptors, the inhibitory neurotransmitter system that regulates anxiety. High progesterone tends to feel calming; the withdrawal in late luteal drives premenstrual anxiety, irritability, and emotional reactivity.

Suppresses prolactin and milk production. Progesterone is one reason breast tissue feels denser and more tender in luteal phase.

Why the late-luteal drop matters

The single most important fact about progesterone in cycle syncing is the late-luteal withdrawal effect. The pattern:

  1. Two weeks of high progesterone in early-to-mid luteal phase. GABA tone is up. Sleep is solid. Anxiety baseline is lower.
  2. Corpus luteum starts dying around days 23 to 25.
  3. Progesterone drops sharply. Allopregnanolone drops with it. GABA tone drops.
  4. The brain that adapted to high inhibitory tone now experiences a relative excitatory state. Anxiety, irritability, sleep disruption, mood lability.
  5. Menstruation begins. The cycle restarts.

This is the dominant model for PMS and PMDD. It is also why "treating PMS" by supplementing progesterone often does not work: the issue is the rate of change, not the absolute level.

Progesterone and pregnancy

If pregnancy occurs, the corpus luteum continues producing progesterone for the first 8 to 10 weeks of pregnancy, before the placenta takes over. Adequate progesterone is essential for maintaining early pregnancy; low progesterone is associated with miscarriage risk in the first trimester.

This is the reason post-ovulation pregnancy tests measure hCG, not progesterone directly: hCG signals that the corpus luteum should keep producing progesterone instead of dying.

Conditions involving progesterone

  • Luteal phase defect. Inadequate progesterone production in the luteal phase. Associated with short luteal phase (under 10 days) and early miscarriage. Diagnosis is contested.
  • PMS and PMDD. Both attributed to abnormal sensitivity to the late-luteal progesterone withdrawal, not to absolute progesterone levels.
  • Perimenopause. Progesterone tends to decline before estrogen, leading to relative estrogen dominance and the symptoms that pattern produces.
  • Anovulatory cycles. No ovulation means no corpus luteum, which means no progesterone production. The cycle still has follicular hormonal events but no luteal phase in the hormonal sense.

Synthetic progestins

"Progestin" refers to synthetic compounds that mimic progesterone. They are not chemically identical to natural progesterone, and their effects diverge in important ways:

Synthetic progestins do not produce the same GABAergic, mood, or sleep effects as natural progesterone. Some users feel notably different on progestin-based methods because of this, including mood-related side effects. The method-by-method guide covers each method's cycle implications.

Progesterone testing

A mid-luteal progesterone test (roughly day 21 of a 28-day cycle, or 7 days after suspected ovulation) is the clinical standard for confirming ovulation occurred. A level above 3 ng/mL confirms ovulation; levels above 10 ng/mL indicate adequate corpus luteum function.

For irregular cycles, test 7 days before the next expected period rather than fixed day 21.

Related reading